stella
beta
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study — Stella
Recruiting
Back to Castration-Resistant Prostate Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
View full record on ClinicalTrials.gov